Pharmaceutical Jurisprudence and
Ethics (Red PACOP)
D - answersThe following persons shall be liable for violation(s) of RA 8203 except:
A. the manufacturer of the counterfeit drugs
B. importer or agents of counterfeit drugs
C. the registered pharmacist who has actual or constructive knowledge about the counterfeit drugs
D. the registered pharmacist who has no actual or constructive knowledge about the counterfeit drugs
E. none
D - answersWhich of the following statement is/are true for detail man?
A. an initial fee of twenty pesos is needed upon registration
B. he shall be, preferably a graduate of a College of Pharmacy
C. to be employed, he needs to possess the necessary credentials issued by the PRC
D. only A and B
E. All of the above
C - answersThis order gives comprehensive guidelines on the registration of pharmaceutical products to be
consistent with RA 6675:
A. AO 220
B. AO 42
C. AO 67
D. AO 90
E. AO 56
B - answersThis order defines rules & regulations governing the registration and sale of herbals and/or
traditional drugs to ensure their quality and safety:
A. AO 220
,B. AO 42
C. AO 56
D. AO 67
E. AO 90
A - answersAny person who shall violate RA 6675, sec 12 (a) for the first conviction shall suffer the penalty of
reprimand which shall be officially recorded in the appropriate books of the:
A. PRC
B.BOP
C. DDB
D. CPE
E. PPhA
B - answersThey ensure the provision of safe, effective and quality drugs, for improved patient care and
quality of life by helping individuals protect themselves against diseases, maintain good health and make the
best use of their medication.
A. teachers
B. pharmacist
C. medical technologist
D. veterinarian
E. pharmacy technician
C - answersAn article intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise
applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering
appearance:
A. device
B. drugs
C. cosmetics
D. poison
E. biologic products
,B - answersIt refers to the approved clinical use of the product based on substantial and scientifically
supported evidence of the safety and efficacy of the drug in the given dosage form:
A. pharmacologic category
B. indication
C. dosage formulation
D. dosage form
E. expiry date
D - answersA drug which has been used for at least five (5) years and involving at least 5,000 patients:
A. investigational drugs
B. established drugs
C. new drugs
D. tried & tested drug
E. Innovation of the tried and tested drug and established drug
A - answersIn Human Studies- Clinical Pharmacology III:
A. Controlled Clinical Trials
B. Safety and Efficacy
C. Tolerance and Safety
D. Post Marketing Surveillance
E. Provisional Monitored Release
A - answersIt is a drug which contains no amount of, or a different active ingredient, or less than 80% of the
active ingredient it purports to possess, as distinguished from an adulterated drug including reduction or loss
of efficacy due to expiration:
A. Counterfeit drug
B. New drug
C. Investigational drug
D. Tried & Tested drug
E. Ethical drug
, B - answersAny person whether related to the senior citizen or not who takes care of him/her as dependent:
A. head of the family
B. benefactor
C. beneficiary
D. protector
E. dependent
B - answersIt is a license issued by the Director General of the Intellectual Property Office (IPO) to exploit a
patented invention without the permission of the patent holder either by manufacture or through parallel
importation:
A. Certificate of Product Registration
B. Compulsory license
C. batch certificate
D. PRC license
E. NOTA
A - answersIt refers to pharmaceutically equivalent or pharmaceutically alternative products that may or may
not be therapeutically equivalent:
A. multisource pharmaceutical products
B. multi-pharmaceutical products
C. source pharmaceutical products
D. generic products
E. pharmaceutical products
D - answersAny person who sells, trades, administers, dispenses, delivers, or gives away to another, on any
term whatsoever, or distributes dispatches in transit or transport dangerous drugs or who act as a broker in
any such transactions:
A. practitioner
B. coddler
C. protector
D. pusher
E. drug syndicate
Ethics (Red PACOP)
D - answersThe following persons shall be liable for violation(s) of RA 8203 except:
A. the manufacturer of the counterfeit drugs
B. importer or agents of counterfeit drugs
C. the registered pharmacist who has actual or constructive knowledge about the counterfeit drugs
D. the registered pharmacist who has no actual or constructive knowledge about the counterfeit drugs
E. none
D - answersWhich of the following statement is/are true for detail man?
A. an initial fee of twenty pesos is needed upon registration
B. he shall be, preferably a graduate of a College of Pharmacy
C. to be employed, he needs to possess the necessary credentials issued by the PRC
D. only A and B
E. All of the above
C - answersThis order gives comprehensive guidelines on the registration of pharmaceutical products to be
consistent with RA 6675:
A. AO 220
B. AO 42
C. AO 67
D. AO 90
E. AO 56
B - answersThis order defines rules & regulations governing the registration and sale of herbals and/or
traditional drugs to ensure their quality and safety:
A. AO 220
,B. AO 42
C. AO 56
D. AO 67
E. AO 90
A - answersAny person who shall violate RA 6675, sec 12 (a) for the first conviction shall suffer the penalty of
reprimand which shall be officially recorded in the appropriate books of the:
A. PRC
B.BOP
C. DDB
D. CPE
E. PPhA
B - answersThey ensure the provision of safe, effective and quality drugs, for improved patient care and
quality of life by helping individuals protect themselves against diseases, maintain good health and make the
best use of their medication.
A. teachers
B. pharmacist
C. medical technologist
D. veterinarian
E. pharmacy technician
C - answersAn article intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise
applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering
appearance:
A. device
B. drugs
C. cosmetics
D. poison
E. biologic products
,B - answersIt refers to the approved clinical use of the product based on substantial and scientifically
supported evidence of the safety and efficacy of the drug in the given dosage form:
A. pharmacologic category
B. indication
C. dosage formulation
D. dosage form
E. expiry date
D - answersA drug which has been used for at least five (5) years and involving at least 5,000 patients:
A. investigational drugs
B. established drugs
C. new drugs
D. tried & tested drug
E. Innovation of the tried and tested drug and established drug
A - answersIn Human Studies- Clinical Pharmacology III:
A. Controlled Clinical Trials
B. Safety and Efficacy
C. Tolerance and Safety
D. Post Marketing Surveillance
E. Provisional Monitored Release
A - answersIt is a drug which contains no amount of, or a different active ingredient, or less than 80% of the
active ingredient it purports to possess, as distinguished from an adulterated drug including reduction or loss
of efficacy due to expiration:
A. Counterfeit drug
B. New drug
C. Investigational drug
D. Tried & Tested drug
E. Ethical drug
, B - answersAny person whether related to the senior citizen or not who takes care of him/her as dependent:
A. head of the family
B. benefactor
C. beneficiary
D. protector
E. dependent
B - answersIt is a license issued by the Director General of the Intellectual Property Office (IPO) to exploit a
patented invention without the permission of the patent holder either by manufacture or through parallel
importation:
A. Certificate of Product Registration
B. Compulsory license
C. batch certificate
D. PRC license
E. NOTA
A - answersIt refers to pharmaceutically equivalent or pharmaceutically alternative products that may or may
not be therapeutically equivalent:
A. multisource pharmaceutical products
B. multi-pharmaceutical products
C. source pharmaceutical products
D. generic products
E. pharmaceutical products
D - answersAny person who sells, trades, administers, dispenses, delivers, or gives away to another, on any
term whatsoever, or distributes dispatches in transit or transport dangerous drugs or who act as a broker in
any such transactions:
A. practitioner
B. coddler
C. protector
D. pusher
E. drug syndicate
